Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
05/29/1991 | EP0429245A2 A therapeutic agent for central nervous diseases |
05/29/1991 | EP0429242A2 Specific binding agents |
05/29/1991 | EP0428876A2 Method for the prevention and treatment of bovine mastitis |
05/29/1991 | EP0428849A2 Retroviral protease inhibitors |
05/29/1991 | EP0428758A1 Albumin preparation and method of producing the same |
05/29/1991 | EP0428636A1 Use of interleukin 2 to treat endotoxinemia. |
05/29/1991 | EP0428603A1 Cytotoxic agent against specific virus infection |
05/29/1991 | DE3938971A1 Leukozytenelastase und kathepsin g blockierendes peptid, dna, vektor, wirtsorganismus und verfahren zu seiner gewinnung sowie pharmazeutisches praeparat Leukocyte elastase and cathepsin G-blocking peptide, dna, vector, host organism and proceed to its recovery as well as pharmaceutical of preparation |
05/29/1991 | DE3938953A1 Klonierung und expression des fuer die blut-hirn-schranke spezifischen proteins ht7 Cloning and expression of the for the blood-brain barrier-specific proteins HT7 |
05/29/1991 | CN1051757A Polypeptide compound and process for preparation thereof |
05/29/1991 | CN1051732A Method for isolating biologically active compounds |
05/28/1991 | US5019647 Antigrowth and anticarconogenic hexapeptide |
05/28/1991 | US5019646 Polypeptides with fibronectin activity |
05/28/1991 | US5019562 Growth inhibiting agent and the use thereof |
05/28/1991 | US5019559 Wound healing using PDGF and IGF-II |
05/28/1991 | US5019556 Human Placental Ribonuclease Inhibitor |
05/28/1991 | US5019513 Anti-bacterial T-cell factor |
05/28/1991 | US5019508 DNA Constructs |
05/28/1991 | US5019385 Novel lymphopine LK 2 and pharmaceutic compositions containing same |
05/28/1991 | US5019382 Treatment of immuno-resistant disease with low-dose interferon |
05/28/1991 | US5019381 Method for lowering cholesterol levels using GM-CSF |
05/28/1991 | US5019368 Antibody bound to antitumor agent |
05/28/1991 | CA2030927A1 Fibrinolytic protein and production method thereof |
05/28/1991 | CA2030850A1 Process for the purification of lipocortins |
05/28/1991 | CA2030720A1 Hexapeptides with sulphate ester groups |
05/28/1991 | CA1284550C Retro-inverso analogs of the bradykinin potentiating peptide bpp*in5a*xx |
05/25/1991 | WO1991008222A1 Physiologically active substance be-16627 |
05/25/1991 | CA2045621A1 Physiologically active substance be-16627 |
05/25/1991 | CA2030770A1 Thrombolytic agents |
05/23/1991 | WO1991007980A1 Compositions for treating ischemia-related neuronal damage |
05/23/1991 | WO1991007188A1 Method for reducing blood cholesterol using arginine |
05/23/1991 | DE3942728C1 New immunologically active proteins derived from Borelia burgdorferiensity polyethylene vessel and a high density polyethylene sealing cap - useful as vaccine and for quick accurate diagnosis of Borelia infections |
05/23/1991 | CA2069413A1 Method for reducing blood cholesterol using arginine |
05/23/1991 | CA2069402A1 Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood cell substitute |
05/23/1991 | CA2030212A1 Peptides |
05/22/1991 | WO1991007386A1 Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors |
05/22/1991 | WO1991007186A1 Anti-inflammatory compositions and methods |
05/22/1991 | EP0428486A1 Polymyxin conjugates |
05/22/1991 | EP0428367A1 Isolation and structural elucidation of the cytostatic linear depsipetide dolastatin 14 |
05/22/1991 | EP0428267A2 Erythropoietin isoforms |
05/22/1991 | EP0428266A1 Anticancer agent |
05/22/1991 | EP0428107A2 Use of quinolyl-and isoquinolyloxanole-2-ones for the production of a medicament for the treatment of multi-drug resistant tumors |
05/22/1991 | EP0428104A2 Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones |
05/22/1991 | EP0427998A2 A pharmaceutical composition for rectal administration of calcitonin |
05/22/1991 | EP0427912A1 Control of microbial growth with lantibiotic/lysozyme formulations |
05/22/1991 | EP0427768A1 Polypeptide pertussis toxin vaccine |
05/22/1991 | EP0237545B1 Production of pluripotent granulocyte colony-stimulating factor |
05/22/1991 | CN1051503A Treatment of conditions and disease |
05/22/1991 | CN1012645B Production of protein |
05/22/1991 | CA2069112A1 Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors |
05/22/1991 | CA2069090A1 Anti-inflammatory compositions and methods |
05/21/1991 | US5017691 Mammalian interleukin-4 |
05/21/1991 | US5017689 Analgesics |
05/21/1991 | US5017688 Peptides involved in the pathogenesis of HIV infection |
05/21/1991 | US5017583 Leukotriene antagonists |
05/21/1991 | US5017567 Steroid antiinflammatory |
05/21/1991 | US5017565 Use of sulfated polysaccharides to inhibit pancreatic cholesterol esterase |
05/21/1991 | US5017560 Porcine prolactin |
05/21/1991 | US5017557 Treatment of infertility with somatotrophin releasing factor |
05/21/1991 | US5017556 Treatment of bleeding disorders using lipid-free tissue factor protein |
05/21/1991 | US5017489 Antibodies |
05/21/1991 | US5017486 Cloning of DNA encoding antibacterial polypeptide precursor |
05/21/1991 | US5017470 Hormones |
05/21/1991 | US5017371 Method for reducing side effects of cancer therapy |
05/21/1991 | US5017370 Improved method of performing angioplasty procedures |
05/21/1991 | CA2030254A1 Methods of treating retroviral infection |
05/18/1991 | WO1991007500A1 Specific binding agents |
05/18/1991 | WO1991007490A1 Protein complexes having factor viii:c activity and production thereof |
05/18/1991 | CA2135744A1 Protein complexes having factor viii:c activity and production thereof |
05/18/1991 | CA2068728A1 Protein complexes having factor viii:c activity and production thereof |
05/18/1991 | CA2066670A1 Specific binding agents |
05/18/1991 | CA2030181A1 Therapeutic agent for central nervous diseases |
05/17/1991 | WO1991007164A1 Cosmetic deodorants |
05/17/1991 | CA2068410A1 Cosmetic deodorants |
05/17/1991 | CA2030006A1 Anhydrous pharmaceutical formulations and dosage forms for the rectal administration of calcitonin |
05/16/1991 | WO1991006866A2 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
05/16/1991 | WO1991006858A1 Novel monoclonal antibody against human platelets |
05/16/1991 | WO1991006668A1 Monoclonal antibodies to basic fibroblast growth factor that inhibit its biological activity |
05/16/1991 | WO1991006658A2 Infective protein delivery system |
05/16/1991 | WO1991006654A1 A method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms |
05/16/1991 | WO1991006639A1 Recombinant production of lactoperoxidase |
05/16/1991 | WO1991006632A1 Inhibition of padgem-mediated cell binding |
05/16/1991 | WO1991006575A1 Hiv-1 specific human monoclonal antibody |
05/16/1991 | WO1991006571A1 A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
05/16/1991 | WO1991006570A1 HYBRID Fc RECEPTOR MOLECULES |
05/16/1991 | WO1991006569A1 Iodothyronine polymers |
05/16/1991 | WO1991006568A1 High molecular weight human angiogenic factors |
05/16/1991 | WO1991006567A1 M-csf derivative, expression vector of said derivative, product of transformation by said vector, and production of them |
05/16/1991 | WO1991006565A1 Physiologically active peptide |
05/16/1991 | WO1991006560A1 Cross-linked tumour necrosis factors |
05/16/1991 | WO1991006321A1 Use of honey as vaccine |
05/16/1991 | WO1991006314A2 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins |
05/16/1991 | WO1991006311A1 Anti-viral material |
05/16/1991 | WO1991006306A1 Antivenoms and methods for making antivenoms |
05/16/1991 | WO1991006293A2 Composition containing 2,3-butanedione monoxime and method for reversibly arresting muscle activity |
05/16/1991 | WO1991004728A3 Use of mullerian inhibiting substance and its agonists and antagonists in the treatment of respiratory distress syndrome |
05/16/1991 | WO1990012879A3 Expression of human apolipoproteins ai-milano in yeast |
05/16/1991 | DE4036130A1 New phosphonamide-contg. polypeptide derivs. - useful as bacterial collagenase inhibitors to treat gangrene and periodontal disease |
05/16/1991 | DE4035456A1 Pharmaceutical composition |
05/16/1991 | DE3937607A1 Verwendung eines antikoagulanz zur behandlung von tumorerkrankungen Use of an anticoagulant in the treatment of tumor diseases |